| 中文名称 | 巴柳氮 |
| 英文名称 | Balsalazide |
| CAS号 | 80573-04-2 |
| 分子式 | C17H15N3O6 |
| 分子量 | 357.32 |
| EINECS号 | 617-116-8 |
| 熔点 | 254-255?C |
| 沸点 | 729.6±60.0 °C(Predicted) |
| 密度 | 1.44±0.1 g/cm3(Predicted) |
| 蒸气压 | 0Pa at 20℃ |
| LogP | 1 at 25℃ and pH7.5 |
| 溶解度 | 可溶于DMSO(少许)、甲醇(少许) |
| 形态 | 固体 |
| 酸度系数(pKa) | 2.97±0.10(Predicted) |
| 颜色 | 黄色到米色 |
|
IL-6
|
STAT3
|
At the endpoint, the protein production of MIP-1β, MCP-1, IL-6, and IL-10 in the colon tissues decrease in concordance with the plasma concentrations of the cytokines. The drug-treated groups reveal lower expression of p-STAT3 compared to the CAC group. In addition, BCL2 decreases and BAX increases markedly in the BSZ+VSL#3 group. Balsalazide is a new 5-aminosalicylic acid (5-ASA) containing prodrug.